263 related articles for article (PubMed ID: 20560679)
1. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
[TBL] [Abstract][Full Text] [Related]
2. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
3. Genotype patterns that contribute to increased risk for or protection from developing heroin addiction.
Nielsen DA; Ji F; Yuferov V; Ho A; Chen A; Levran O; Ott J; Kreek MJ
Mol Psychiatry; 2008 Apr; 13(4):417-28. PubMed ID: 18195715
[TBL] [Abstract][Full Text] [Related]
4. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings.
de Cid R; Fonseca F; Gratacòs M; Gutierrez F; Martín-Santos R; Estivill X; Torrens M
Genes Brain Behav; 2008 Jul; 7(5):515-22. PubMed ID: 18182069
[TBL] [Abstract][Full Text] [Related]
5. Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.
Fonseca F; de la Torre R; Díaz L; Pastor A; Cuyàs E; Pizarro N; Khymenets O; Farré M; Torrens M
PLoS One; 2011 May; 6(5):e19527. PubMed ID: 21589866
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction.
Peles E; Levran O; Randesi M; Ott J; Kreek MJ; Adelson M
J Addict Med; 2019; 13(6):430-435. PubMed ID: 30844877
[TBL] [Abstract][Full Text] [Related]
7. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
Drug Alcohol Depend; 2016 Aug; 165():143-50. PubMed ID: 27289271
[TBL] [Abstract][Full Text] [Related]
8. [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].
Duan LX; Li XL; Hu PW; Luo R; Luo X; Chen YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):194-198. PubMed ID: 29495204
[No Abstract] [Full Text] [Related]
9. Polymorphisms in Stress-Related Genes Are Associated with Reduced Cocaine Abuse and Longer Retention in Methadone Maintenance Treatment for Opioid Use Disorder.
Peles E; Levran O; Randesi M; Ott J; Kreek MJ; Adelson M
Eur Addict Res; 2021; 27(3):198-205. PubMed ID: 33242852
[TBL] [Abstract][Full Text] [Related]
10. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Smith AH; Jensen KP; Li J; Nunez Y; Farrer LA; Hakonarson H; Cook-Sather SD; Kranzler HR; Gelernter J
Mol Psychiatry; 2017 Mar; 22(3):346-352. PubMed ID: 28115739
[TBL] [Abstract][Full Text] [Related]
12. Association of
Duan L; Li X; Yan J; Chen Y; Luo R; Zhang Q; Feng X; Li X
Genet Test Mol Biomarkers; 2020 Jun; 24(6):364-369. PubMed ID: 32407152
[No Abstract] [Full Text] [Related]
13. Impacts of GRIN3A, GRM6 and TPH2 genetic polymorphisms on quality of life in methadone maintenance therapy population.
Wang RY; Chen HJ; Huang CL; Wang JY; Lee TE; Lee HY; Hung CC
PLoS One; 2018; 13(7):e0201408. PubMed ID: 30059533
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
[TBL] [Abstract][Full Text] [Related]
15. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
[TBL] [Abstract][Full Text] [Related]
16. Association study of genetic polymorphisms in
Xie X; Gu J; Zhuang D; Chen X; Zhou Y; Shen W; Li L; Liu Y; Xu W; Hong Q; Chen W; Zhou W; Liu H
Per Med; 2021 Sep; 18(5):423-430. PubMed ID: 34160285
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
[TBL] [Abstract][Full Text] [Related]
18. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.
Crist RC; Doyle GA; Nelson EC; Degenhardt L; Martin NG; Montgomery GW; Saxon AJ; Ling W; Berrettini WH
Pharmacogenomics J; 2018 Jan; 18(1):173-179. PubMed ID: 27958381
[TBL] [Abstract][Full Text] [Related]
20. Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study.
Bawor M; Dennis BB; Tan C; Pare G; Varenbut M; Daiter J; Plater C; Worster A; Marsh DC; Steiner M; Anglin R; Desai D; Thabane L; Samaan Z
Addict Sci Clin Pract; 2015 Oct; 10():19. PubMed ID: 26437921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
